Search | IOVS | ARVO Journals

Showing 1 – 17 of 17

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2025

Subcutaneous Migaldendranib Reduces Anti-VEGF Treatment Burden; A Unique Therapeutic Platform to Treat Retinal Vascular Disease

Jeffrey Cleland; Allen Y H Hu; Raj K Maturi; Michael Andrew Singer; Sabin Dang; David RP Almeida; Robert Wong; Ramanath Bhandari; Lynn Huang; Seong Y Lee; Joseph T Gilbert; Pete H Hsu; Joel Gutierrez; Sue Schneider

Invest. Ophthalmol. Vis. Sci.. 2025; 66(8):4683.

ARVO Annual Meeting Abstract June 2025

Visual Acuity and Durability Outcomes of Faricimab Compared to Other Anti–Vascular Endothelial Growth Factor Agents for Diabetic Macular Edema

Nathan Macha; Lucas Rowe; Nitika Aggarwal; Raj K Maturi

Invest. Ophthalmol. Vis. Sci.. 2025; 66(8):2389.

ARVO Annual Meeting Abstract June 2025

Title: Preliminary Safety and Efficacy of OCU410 for Treatment of Geographic Atrophy: Phase 1/2 OCU410: The Age-related Macular Degeneration (ArMaDa) Study update.

Syed Mahmood Shah; Shailesh Gupta; Benjamin Bakall; Lejla Vajzovic; Majda Hadziahmetovic; Yoshihiro Yonekawa; Raj K Maturi; Kevin Binder; Michael J Borne; Venkata R M Chavali; Sanjay Mitter; Roshan George; Alex Berezow; Huma Qamar

Invest. Ophthalmol. Vis. Sci.. 2025; 66(8):3675.

ARVO Annual Meeting Abstract June 2024

Senolytic drug candidate in wet AMD demonstrates benefit with Multifocal ERG testing

Nathan Macha; Raj K Maturi; Sheeraz Naqvi; Sharon Klier; Ghosh Anirvan

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):5390.

ARVO Annual Meeting Abstract June 2024

Treatment and Visual Outcome Analysis of Central Serous Retinopathy in the United States: A Retrospective Large Database Study

Lauren Burgett; Jay Chhablani; Raj K Maturi

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):1709.

ARVO Annual Meeting Abstract June 2024

Interim results from the PRISM randomized phase 2 dose expansion trial evaluating 4D-150 in high anti-VEGF need individuals with neovascular (wet) age-related macular degeneration

Arshad M. Khanani; Allen Hu; David Aaron Eichenbaum; Raj K Maturi; Veeral S Sheth; Albert O Edwards; Sunil Gupta; Joel Pearlman; Suhail Alam; Jeffrey S Heier; Fuad Makkouk; Andres Emanuelli; Dante Pieramici; John A Wells; Chyong Nien; Robert Kim

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):4356.

ARVO Annual Meeting Abstract June 2023

A Randomized Trial of Intravitreous Anti-VEGF for Prevention of Vision Threatening Complications of Diabetic Retinopathy (Protocol W)

Raj K Maturi

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):2812.

ARVO Annual Meeting Abstract June 2022

A Phase I/IIa trial examining the safety and efficacy of BI-X in patients with diabetic macular ischemia and diabetic retinopathy: The HORNBILL study

Sobha Sivaprasad; Quan Dong Nguyen; Chirag Jhaveri; Harsha Sen; David M Brown; Raj K Maturi; Abosede Cole; Andrea Giani; Elizabeth Pearce

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):2308.

ARVO Annual Meeting Abstract June 2022

Race and Insurance based differences in the outcome of anti-vascular endothelial growth factor treatment of diabetic retinopathy - an analysis of 43,274 patient eyes using the IRIS® Registry (Intelligent Research in Sight)

Jay Maturi; Vikas rammohan Maturi; Charles Li; Flora Lum; Thomas A Ciulla; Raj K Maturi

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):565 – A0130.

ARVO Annual Meeting Abstract June 2021

The HORNBILL study: A Phase I/IIa trial examining the safety of BI-X in patients with diabetic macular ischemia and diabetic retinopathy treated with pan-retinal photocoagulation

Quan Dong Nguyen; Harsha Sen; Raj K Maturi; Louis-Josef Bour; Sobha Sivaprasad; Elizabeth Pearce; Victor Chong

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):1074.

ARVO Annual Meeting Abstract June 2021

A Randomized Trial of Intravitreous Anti-VEGF for Prevention of Vision Threatening Complications of Diabetic Retinopathy (Protocol W)

Raj K Maturi

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):1041.

ARVO Annual Meeting Abstract June 2017

Abicipar pegol in neovascular age-related macular degeneration (nAMD): comparability between Japanese and non-Japanese patients, and treatment effects on polypoidal choroidal vasculopathy (PCV) and non-PCV patients

Derek Kunimoto; Masahito Ohji; Raj K Maturi; Tetsuju Sekiryu; Ying Wang; Grace Pan; Xiao-Yan Li; Susan Schneider

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):1959.

ARVO Annual Meeting Abstract September 2016

Intravitreous Plasma Kallikrein (PK) Inhibition for Diabetic Macular Edema: A Phase 1 Study of the Novel PK Inhibitor KVD001

Jennifer K Sun; Raj K Maturi; David S Boyer; John A Wells; Victor H Gonzalez; Robert Tansley; Helen Hernandez; Lloyd P Aiello

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12)

ARVO Annual Meeting Abstract April 2014

Three-year, Randomized, Sham-controlled, Phase III Study of Dexamethasone Intravitreal Implant in Patients with Diabetic Macular Edema

Rubens Belfort, Jr.; David S Boyer; Young Hee Yoon; Francesco Bandello; Raj K Maturi; Albert J Augustin; Xiao-Yan Li; Harry Cui; Yehia Hashad; Scott M Whitcup; Ozurdex MEAD Study Group

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):1706.

ARVO Annual Meeting Abstract April 2014

Long-term Efficacy and Safety of Dexamethasone Intravitreal Implant in Phakic and Pseudophakic Eyes with Diabetic Macular Edema

Young Hee Yoon; David S Boyer; Rubens Belfort, Jr.; Francesco Bandello; Raj K Maturi; Albert J Augustin; Xiao-Yan Li; Harry Cui; Yehia Hashad; Scott M Whitcup; Ozurdex MEAD Study Group

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):1779.

ARVO Annual Meeting Abstract December 2002

Multifocal Electroretinography May Be an Early Indicator of Hydroxychloroquine Toxicity

M Yu; RK Maturi

Invest. Ophthalmol. Vis. Sci.. 2002; 43(13):1176.

ARVO Annual Meeting Abstract December 2002

Tobacco Smoking Negatively Affects the Outcome of Retinal Detachment Repair

AJ Franklin; M Yu; RK Maturi

Invest. Ophthalmol. Vis. Sci.. 2002; 43(13):635.

NARROW

Content Type

Journal

Article Type

Specify Date Range

Subcutaneous Migaldendranib Reduces Anti-VEGF Treatment Burden; A Unique Therapeutic Platform to Treat Retinal Vascular Disease

Visual Acuity and Durability Outcomes of Faricimab Compared to Other Anti–Vascular Endothelial Growth Factor Agents for Diabetic Macular Edema

Title: Preliminary Safety and Efficacy of OCU410 for Treatment of Geographic Atrophy: Phase 1/2 OCU410: The Age-related Macular Degeneration (ArMaDa) Study update.

Senolytic drug candidate in wet AMD demonstrates benefit with Multifocal ERG testing

Treatment and Visual Outcome Analysis of Central Serous Retinopathy in the United States: A Retrospective Large Database Study

Interim results from the PRISM randomized phase 2 dose expansion trial evaluating 4D-150 in high anti-VEGF need individuals with neovascular (wet) age-related macular degeneration

A Randomized Trial of Intravitreous Anti-VEGF for Prevention of Vision Threatening Complications of Diabetic Retinopathy (Protocol W)

A Phase I/IIa trial examining the safety and efficacy of BI-X in patients with diabetic macular ischemia and diabetic retinopathy: The HORNBILL study

Race and Insurance based differences in the outcome of anti-vascular endothelial growth factor treatment of diabetic retinopathy - an analysis of 43,274 patient eyes using the IRIS® Registry (Intelligent Research in Sight)

The HORNBILL study: A Phase I/IIa trial examining the safety of BI-X in patients with diabetic macular ischemia and diabetic retinopathy treated with pan-retinal photocoagulation

A Randomized Trial of Intravitreous Anti-VEGF for Prevention of Vision Threatening Complications of Diabetic Retinopathy (Protocol W)

Abicipar pegol in neovascular age-related macular degeneration (nAMD): comparability between Japanese and non-Japanese patients, and treatment effects on polypoidal choroidal vasculopathy (PCV) and non-PCV patients

Intravitreous Plasma Kallikrein (PK) Inhibition for Diabetic Macular Edema: A Phase 1 Study of the Novel PK Inhibitor KVD001

Three-year, Randomized, Sham-controlled, Phase III Study of Dexamethasone Intravitreal Implant in Patients with Diabetic Macular Edema

Long-term Efficacy and Safety of Dexamethasone Intravitreal Implant in Phakic and Pseudophakic Eyes with Diabetic Macular Edema

Multifocal Electroretinography May Be an Early Indicator of Hydroxychloroquine Toxicity

Tobacco Smoking Negatively Affects the Outcome of Retinal Detachment Repair

To View More...

You must be signed into an individual account to use this feature.